NFIB and neoplasm: The discovery of the translocation between chromosome 6q and 9p and the identification of the resultant MYB-NFIB fusion in 2009, led to an important insight into the molecular pathogenesis of this malignancy and highlighted the tumor driving role of the MYB (myeloblastosis) proto-oncogene [4].